Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Advanced Search
Wizards and Analytics Search
Simple Search
By Subject Area
Sales and Marketing > New Product Development and Launch > Optimizing Product Portfolio > Lifecycle Management
Lifecycle Management Research

Managing Quality to Drive Growth: Meeting Proceedings 
Non-members: Click here to download a complimentary excerpt of "Managing Quality to Drive Growth: Meeting Proceedings" OVERVIEW Applying lessons learned from Six Sigma and Lean deployments in manufacturing to areas that drive corporate growth, such as sales, marketing and new product development, is the current hurdle for companies looking to stimulate organic growth... (ID 4982)
Companies Profiled: Boeing, BP Amoco, CenterPoint Energy, LifeScan, more ...
Price: $750.00   Free Excerpt Available
Effectiveness of Pharmaceutical Lifecycle Management Tactics 
Study Overview This survey-based benchmarking exchange was designed to understand how companies can extend and optimize the value of pharmaceutical products as they enter the late mature phase of the product life cycle... (ID 4864)
Companies Profiled: Abbott Laboratories, Solvay America, Sanofi-Synthelabo Inc., Pfizer, more ...
Price: $1320.00
Timing, Structuring and Staffing for Drug Delivery System Development 
Study Overview As there are more me-too drugs crowding the marketplace, it is becoming critical to differentiate products through new formulations and delivery methods... (ID 4782)
Companies Profiled: Amgen, Vital Therapies, Bayer, Theratechnologies, more ...
Price: $795.00
Case Studies in Successful Re-Launch: Zithromax and Wellbutrin 
Non-members: Click here to sign-up for a complimentary tour of "Case Studies in Successful Re-Launch: Zithromax and Wellbutrin" Study Overview Successfully re-launching a pharmaceutical product is a difficult feat... (ID 4776)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1365.61   Free Excerpt Available
Product Character & Position: Choosing Changes for New Growth 
Non-members: Click here to sign-up for a complimentary tour of "Product Character & Position: Choosing Changes for New Growth" Study Overview Most companies eventually must face the daunting task of re-launching a pharmaceutical product... (ID 4771)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1124.00
Pharmaceutical Brand Leadership: Getting There and Staying On Top 
Study Overview Why do some pharmaceutical brands fail and others succeed? This 51-slide presentation identifies the specific factors that drive some brands such as Celebrex and Lipitor to the top of their therapeutic classes and also describes how they retain their #1 positions... (ID 4622)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Amgen, AstraZeneca, more ...
Price: $1840.00
Life Cycle Management for Pharmaceutical Launches 
Life cycle management (LCM) ultimately drives the long-term success of any pharmaceutical product... (ID 4573)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline , more ...
Price: $1424.95
Enhancing Brand Performance Through Sales & Marketing Excellence 
Leading pharmaceutical companies have developed strategies over the last several years on how to distinguish their brands in highly competitive therapeutic markets... (ID 4485)
Companies Profiled: Merck, Bristol-Myers Squibb, CWC, Abbott, more ...
Price: $2416.00
Portfolio Optimization: Meeting Proceedings 
This report includes summaries from presentations delivered at the Q1 2003 meeting of Best Practices' Global Benchmarking Council... (ID 4416)
Companies Profiled: Eli Lilly, Peppers & Rogers, Devonshire International, Duke Energy, more ...
Price: $299.95
Addressing Medical Needs and Regulatory Concerns as Part of Brand Strategy 
Patient safety is one of the Food and Drug Administration’s main concerns about multiple trademarked products... (ID 4306)
Industries Profiled: Consulting, Manufacturing, Pharmaceutical, Financial Services
Price: $839.95
Positioning and Pricing for Brand Success 
STUDY OVERVIEW This 16-page document, geared to pharmaceutical marketing and brand team executives, examines how best practice companies make trademark and branding decisions about pricing, positioning and promotion... (ID 4305)
Companies Profiled: AstraZeneca; Bristol-Myers Squibb; Pfizer; Sanofi-aventis; Novartis; Merck; GSK
Price: $839.95
Sales Force Deployment that Optimizes Brand Communications 
Sales force assignment is an often overlooked management factor in the trademark and branding process... (ID 4304)
Industries Profiled: Consulting, Manufacturing, Pharmaceutical, Financial Services
Price: $659.95
Trademark Branding Decisions: Setting a Strategy 
Trademark strategy no longer refers just to setting the course for developing, launching and marketing a single product... (ID 4303)
Industries Profiled: Consulting, Manufacturing, Pharmaceutical, Financial Services
Price: $839.95

 


All contents copyright © 1999-2012 Best Practices, LLC 6350 Quadrangle Drive, Chapel Hill, NC 27517 USA (919) 403-0251.
Site Map | Please see our Terms and Conditions of Use and Privacy Policy.

This site is optimized for 4.0 and higher versions of Microsoft Internet Explorer and Netscape Navigator.
If you experience difficulties using our e-commerce system, please check your browser version and our FAQs.